Dr. Sarah Nicholas, MD

NPI: 1619227584
Total Payments
$25,517
2024 Payments
$1,145
Companies
9
Transactions
41

Payment Breakdown by Category

Other$13,016 (51.0%)
Consulting$6,790 (26.6%)
Travel$4,515 (17.7%)
Food & Beverage$1,004 (3.9%)
Education$191.53 (0.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $13,016 5 51.0%
Consulting Fee $6,790 2 26.6%
Travel and Lodging $4,515 9 17.7%
Food and Beverage $1,004 23 3.9%
Education $191.53 2 0.8%

Top Paying Companies

Company Total Records Latest Year
Sumitomo Pharma America, Inc. $15,446 21 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $9,423 4 $0 (2024)
Enzyvant Therapeutics, Inc. $176.43 1 $0 (2022)
Zimmer Biomet Holdings, Inc. $164.60 2 $0 (2018)
Horizon Therapeutics plc $128.05 5 $0 (2022)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $68.07 5 $0 (2022)
ADMA BioManufacturing LLC $55.53 1 $0 (2022)
Veloxis Pharmaceuticals, Inc. $29.66 1 $0 (2022)
CSL Behring $25.02 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,145 8 Sumitomo Pharma America, Inc. ($1,095)
2023 $16,191 16 Sumitomo Pharma America, Inc. ($14,351)
2022 $7,950 10 Takeda Pharmaceuticals U.S.A., Inc. ($7,544)
2021 $67.12 5 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($52.02)
2018 $164.60 2 Zimmer Biomet Holdings, Inc. ($164.60)

All Payment Transactions

41 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
10/04/2024 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Travel and Lodging In-kind items and services $651.95 General
Category: CONGENITAL ATHYMIA
10/04/2024 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Travel and Lodging In-kind items and services $248.02 General
Category: CONGENITAL ATHYMIA
10/04/2024 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Food and Beverage In-kind items and services $102.91 General
Category: CONGENITAL ATHYMIA
10/03/2024 Sumitomo Pharma America, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $33.22 General
10/03/2024 Sumitomo Pharma America, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $30.30 General
10/03/2024 Sumitomo Pharma America, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $28.96 General
07/30/2024 Takeda Pharmaceuticals U.S.A., Inc. LIVTENCITY (Drug) Food and Beverage In-kind items and services $24.16 General
Category: IMMUNOLOGY
05/15/2024 CSL Behring Hizentra (Biological) Food and Beverage In-kind items and services $25.02 General
Category: Immunology
06/23/2023 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,380.00 General
Category: CONGENITAL ATHYMIA
06/23/2023 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Travel and Lodging Cash or cash equivalent $1,542.40 General
Category: CONGENITAL ATHYMIA
06/23/2023 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Travel and Lodging Cash or cash equivalent $271.27 General
Category: CONGENITAL ATHYMIA
06/23/2023 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Food and Beverage In-kind items and services $128.26 General
Category: CONGENITAL ATHYMIA
06/23/2023 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Food and Beverage In-kind items and services $86.72 General
Category: CONGENITAL ATHYMIA
06/23/2023 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Food and Beverage In-kind items and services $4.45 General
Category: CONGENITAL ATHYMIA
02/09/2023 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Consulting Fee Cash or cash equivalent $4,950.00 General
Category: CONGENITAL ATHYMIA
02/09/2023 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Travel and Lodging Cash or cash equivalent $144.00 General
Category: CONGENITAL ATHYMIA
01/18/2023 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $1,840.00 General
01/15/2023 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Travel and Lodging In-kind items and services $449.74 General
Category: CONGENITAL ATHYMIA
01/15/2023 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Travel and Lodging In-kind items and services $259.32 General
Category: CONGENITAL ATHYMIA
01/14/2023 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Food and Beverage In-kind items and services $45.60 General
Category: CONGENITAL ATHYMIA
01/14/2023 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Food and Beverage In-kind items and services $17.09 General
Category: CONGENITAL ATHYMIA
01/13/2023 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Travel and Lodging In-kind items and services $699.80 General
Category: CONGENITAL ATHYMIA
01/13/2023 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Travel and Lodging In-kind items and services $248.50 General
Category: CONGENITAL ATHYMIA
01/13/2023 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Food and Beverage In-kind items and services $123.98 General
Category: CONGENITAL ATHYMIA
12/01/2022 Takeda Pharmaceuticals U.S.A., Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $7,544.00 General

About Dr. Sarah Nicholas, MD

Dr. Sarah Nicholas, MD is a Allergy & Immunology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/18/2012. The National Provider Identifier (NPI) number assigned to this provider is 1619227584.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sarah Nicholas, MD has received a total of $25,517 in payments from pharmaceutical and medical device companies, with $1,145 received in 2024. These payments were reported across 41 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($13,016).

Practice Information

  • Specialty Allergy & Immunology
  • Other Specialties Pediatrics
  • Location Houston, TX
  • Active Since 09/18/2012
  • Last Updated 10/02/2024
  • Taxonomy Code 207RA0201X
  • Entity Type Individual
  • NPI Number 1619227584

Products in Payments

  • RETHYMIC (Drug) $15,354
  • Tapered Screw (Device) $164.60
  • ACTIMMUNE (Drug) $128.05
  • XIFAXAN (Drug) $68.07
  • Envarsus (Drug) $29.66
  • Hizentra (Biological) $25.02
  • LIVTENCITY (Drug) $24.16

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Allergy & Immunology Doctors in Houston